BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 27035564)

  • 21. Cancer-associated fibroblasts induce epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer via CXCL12/CXCR4 axis.
    Zhang F; Cui JY; Gao HF; Yu H; Gao FF; Chen JL; Chen L
    Future Oncol; 2020 Nov; 16(32):2619-2633. PubMed ID: 32804554
    [No Abstract]   [Full Text] [Related]  

  • 22. miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12.
    Zhang J; Liu J; Liu Y; Wu W; Li X; Wu Y; Chen H; Zhang K; Gu L
    Biomed Pharmacother; 2015 Aug; 74():215-21. PubMed ID: 26349988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer stromal fibroblasts promote the generation of CD44+CD24- cells through SDF-1/CXCR4 interaction.
    Huang M; Li Y; Zhang H; Nan F
    J Exp Clin Cancer Res; 2010 Jun; 29(1):80. PubMed ID: 20569497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
    Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
    J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
    Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
    Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD146 attenuation in cancer-associated fibroblasts promotes pancreatic cancer progression.
    Zheng B; Ohuchida K; Chijiiwa Y; Zhao M; Mizuuchi Y; Cui L; Horioka K; Ohtsuka T; Mizumoto K; Oda Y; Hashizume M; Nakamura M; Tanaka M
    Mol Carcinog; 2016 Nov; 55(11):1560-1572. PubMed ID: 26373617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-148b reverses cisplatin-resistance in non-small cell cancer cells via negatively regulating DNA (cytosine-5)-methyltransferase 1(DNMT1) expression.
    Sui C; Meng F; Li Y; Jiang Y
    J Transl Med; 2015 Apr; 13():132. PubMed ID: 25927928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
    Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
    Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
    Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
    Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
    Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
    Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-8 from CD248-expressing cancer-associated fibroblasts generates cisplatin resistance in non-small cell lung cancer.
    Wu J; Zhang Q; Wu J; Yang Z; Liu X; Lou C; Wang X; Peng J; Zhang J; Shang Z; Xiao J; Wang N; Zhang R; Zhou J; Wang Y; Hu Z; Zhang R; Zhang J; Zeng Z
    J Cell Mol Med; 2024 Feb; 28(4):e18185. PubMed ID: 38396325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpressed D2 Dopamine Receptor Inhibits Non-Small Cell Lung Cancer Progression through Inhibiting NF-κB Signaling Pathway.
    Wu XY; Zhang CX; Deng LC; Xiao J; Yuan X; Zhang B; Hou ZB; Sheng ZH; Sun L; Jiang QC; Zhao W
    Cell Physiol Biochem; 2018; 48(6):2258-2272. PubMed ID: 30114693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reverse of non-small cell lung cancer drug resistance induced by cancer-associated fibroblasts via a paracrine pathway.
    Zhang Q; Yang J; Bai J; Ren J
    Cancer Sci; 2018 Apr; 109(4):944-955. PubMed ID: 29383798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7.
    Cui R; Kim T; Fassan M; Meng W; Sun HL; Jeon YJ; Vicentini C; Tili E; Peng Y; Scarpa A; Liang G; Zhang YK; Chakravarti A; Croce CM
    Oncotarget; 2015 Sep; 6(26):21802-15. PubMed ID: 26307684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
    Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
    Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
    Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
    Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic miR-9 is a target of erlotinib in NSCLCs.
    Chen X; Zhu L; Ma Z; Sun G; Luo X; Li M; Zhai S; Li P; Wang X
    Sci Rep; 2015 Nov; 5():17031. PubMed ID: 26593208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between cancer cells and cancer-associated fibroblasts after cisplatin treatment promotes cancer cell regrowth.
    Hisamitsu S; Miyashita T; Hashimoto H; Neri S; Sugano M; Nakamura H; Yamazaki S; Ochiai A; Goto K; Tsuboi M; Ishii G
    Hum Cell; 2019 Oct; 32(4):453-464. PubMed ID: 31441010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.